Biosensors & POCT– category –
-
Abbott Submits Dual Glucose-Ketone Sensor ‘Libre Duo’ to US FDA for DKA Prevention After European CE Mark
MedTech Dive USA Overview Abbott has filed an FDA application to launch its dual glucose-ketone sensor, Libre Duo, in the U.S. after receiving Europe's CE mark. Approval is expected by year-end, with the device aiming to prevent diabetic... -
ThePrint Reports Biosensors and Microfluidics Cut Foodborne Pathogen Detection from Days to Minutes, Accelerating Food Safety Across Supply Chain
ThePrint India Overview ThePrint reports technological advancements in food safety diagnostics leveraging biosensors and microfluidics to rapidly detect foodborne pathogens like Salmonella and E. coli in minutes, rather than days. These ... -
Revolutionizing Diagnostics: Smart Contact Lenses Harness Tear Biosensors for Early Neurodegenerative Disease Detection
Facebook Unknown Overview Integrating nanoscale biosensors and wireless transmitters, smart contact lenses are emerging as a promising technology for the early, non-invasive detection of neurodegenerative diseases such as Alzheimer's, Pa... -
UAE Breakthrough: Wearable Ketone Monitor Slashes DKA Emergencies by 60% for Type 1 Diabetics, Poised to Revolutionize Diabetes Management
Facebook UAE Overview Researchers in the UAE have engineered a pioneering wearable continuous ketone monitor (CKM) that tracks interstitial fluid ketone levels to avert diabetic ketoacidosis (DKA) in Type 1 diabetics. A clinical trial in... -
bioRxiv Preprint Unveils ELDR-Glo: A Genetically-Encoded Fluorescent Biosensor for Measuring Time Since Last Cell Cycle and Quiescence Depth
bioRxiv USA Overview A preprint on bioRxiv introduces ELDR-Glo, a genetically-encoded fluorescent biosensor designed to estimate relative cell age or the time elapsed since the last cell cycle. This biosensor integrates replication-coupl... -
Abingdon Health Showcases Future of POCT: Genalyte Merlin Runs 26 Tests in 30 Minutes, Oasis Diagnostics Offers Non-Invasive Saliva Systems
Abingdon Health UK Overview Abingdon Health announced innovations in next-generation Point-of-Care Diagnostics (POCT), highlighting Genalyte’s Merlin instrument, which received FDA clearance for a TSH assay in 2024 and can now perform up... -
Johns Hopkins’ MOSAIC System: AI-Powered Wearables Rival Invasive Arterial Lines for ICU Blood Pressure Accuracy
Facebook USA Overview Johns Hopkins researchers have unveiled the MOSAIC system, an AI-powered wearable platform offering non-invasive, continuous blood pressure monitoring in ICUs with accuracy on par with invasive arterial lines. This ... -
Biosensors & POCT Weekly Report August 16, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report August 16, 2026 (PDF) — Download Weekly Report August 16, 2026 (PDF) — DownloadDownload 🎙 Podcast August 16, ... -
Adaptyx Biosciences Launches ARPA-H Backed $4 Million Study: Identifying Objective Molecular Signatures of Chronic Pain with Multi-Analyte Wearable Biosensor
BioSpace America Overview Stanford spin-out Adaptyx Biosciences, in collaboration with Attune Neurosciences, has initiated a 24-month, $4 million study to identify objective molecular signatures for chronic pain. Funded by ARPA-H’s EVIDE... -
Vexev Raises $6 Million to Drive FDA Approval and US Commercialization of VxWave Robotic Vascular Imaging Platform, Total Funding Reaches $19 Million
Pulse 2.0 (via Facebook) Australia Overview Australian medical robotics firm Vexev has secured $6 million in new funding to accelerate FDA regulatory activities and US commercialization of its AI-driven robotic vascular ultrasound platfo...
